CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-16 | Zaderej Karen L. CEO | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2021-03-16 | Ottinger Bradley General Counsel and CCO | Grant or award · Employee Stock Option (right to purchase) | +23,500 | 23,500 | ||
| 2021-03-16 | Ottinger Bradley General Counsel and CCO | Grant or award · Restricted Stock Units | +11,800 | 11,800 | ||
| 2021-03-16 | Ottinger Bradley General Counsel and CCO | Grant or award · Restricted Stock Units | +7,690 | 19,490 | ||
| 2021-03-16 | Sandberg Eric Chief Commercial Officer | Grant or award · Employee Stock Option (right to purchase) | +23,500 | 23,500 | ||
| 2021-03-16 | Sandberg Eric Chief Commercial Officer | Grant or award · Restricted Stock Units | +11,800 | 11,800 | ||
| 2021-03-16 | MARIANI PETER J EVP & Chief Financial Officer | Grant or award · Employee Stock Option (right to purchase) | +61,000 | 61,000 | ||
| 2021-03-16 | MARIANI PETER J EVP & Chief Financial Officer | Grant or award · Restricted Stock Units | +30,500 | 30,500 | ||
| 2021-03-16 | Scopelianos Angelo Chief R&D Officer | Grant or award · Employee Stock Option (right to purchase) | +34,000 | 34,000 | ||
| 2021-03-16 | Scopelianos Angelo Chief R&D Officer | Grant or award · Restricted Stock Units | +16,500 | 16,500 | ||
| 2021-02-25 | Freitag Gregory Gene Director | Sale | −24,000 | $22.06 | $529K | 228,352 |
| 2021-02-18 | Donovan Michael Patrick VP Operations | Sale | −1,808 | $19.15 | $35K | 40,839 |
| 2021-02-17 | Scopelianos Angelo Chief R&D Officer | Shares withheld for taxes | −406 | $18.71 | $8K | 7,046 |
| 2021-02-17 | Friedman Mark Louis VP, Regulatory & Quality | Shares withheld for taxes | −590 | $18.70 | $11K | 13,116 |
| 2021-02-17 | Friedman Mark Louis VP, Regulatory & Quality | Shares withheld for taxes | −361 | $18.71 | $7K | 13,936 |
| 2021-02-17 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Shares withheld for taxes | −1,542 | $18.70 | $29K | 67,223 |
| 2021-02-17 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Shares withheld for taxes | −322 | $18.70 | $6K | 68,082 |
| 2021-02-17 | Sandberg Eric Chief Commercial Officer | Shares withheld for taxes | −903 | $18.70 | $17K | 3,223 |
| 2021-02-17 | Donovan Michael Patrick VP Operations | Shares withheld for taxes | −590 | $18.71 | $11K | 42,179 |
| 2021-02-17 | Donovan Michael Patrick VP Operations | Shares withheld for taxes | −207 | $18.71 | $4K | 42,647 |
Page 37 of 69 · 1,376 trades